Array
(
[id] => 520
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/520.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => TTE is recommended in patients with poor functional capacity and/or high NT-proBNP/BNP, or if murmurs are detected before high-risk NCS, in order to undertake risk-reduction strategies. (Evidence: Level B，Recommendation: Class Ⅰ)
[laiyuan] => 心功能储备差和（或） NT-proBNP/BNP 高，或有心脏杂音的患者在高风险NCS术前应检查经胸超声心动图以便采取降低风险的策略（证据级别：Level B ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
心功能储备差和（或） NT-proBNP/BNP 高，或有心脏杂音的患者在高风险NCS术前应检查经胸超声心动图以便采取降低风险的策略（证据级别：Level B ；推荐强度：Class Ⅰ）
TTE is recommended in patients with poor functional capacity and/or high NT-proBNP/BNP, or if murmurs are detected before high-risk NCS, in order to undertake risk-reduction strategies. (Evidence: Level B，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 521
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/521.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => If a patient scheduled for elective NCS has chest pain or other symptoms suggestive of undetected CAD, further diagnostic work-up before NCS is recommended. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 如果计划进行择期NCS的患者有胸痛或其他症状而提示未检测到冠心病,则推荐在非心脏手术之前进行进一步的诊断检查。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
如果计划进行择期NCS的患者有胸痛或其他症状而提示未检测到冠心病,则推荐在非心脏手术之前进行进一步的诊断检查。（证据级别：Level C ；推荐强度：Class Ⅰ）
If a patient scheduled for elective NCS has chest pain or other symptoms suggestive of undetected CAD, further diagnostic work-up before NCS is recommended. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 522
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/522.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => If a patient in need of acute NCS also has chest pain or other symptoms suggestive of undetected CAD, a multidisciplinary assessment approach is recommended to choose the treatment with lowest total risk for the patient. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 如果需要急诊NCS的患者同时有胸痛或其他提示未发现冠心病的症状，侧建议采用多学科评估方法来选择治疗，使患者的总风险最低。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
如果需要急诊NCS的患者同时有胸痛或其他提示未发现冠心病的症状，侧建议采用多学科评估方法来选择治疗，使患者的总风险最低。（证据级别：Level C ；推荐强度：Class Ⅰ）
If a patient in need of acute NCS also has chest pain or other symptoms suggestive of undetected CAD, a multidisciplinary assessment approach is recommended to choose the treatment with lowest total risk for the patient. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 523
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/523.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with symptomatic severe AR or asymptomatic severe AR and LVESD＞50 mm or LVESDi (LVESD/BSA)＞25 mm/m2 (in patients with small body size) or resting LVEF ≤50%, valve surgery is recommended prior to elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 对于有症状的重度主动脉瓣反流或无症状的重度主动脉瓣反流，且LVESD＞0.50 毫米或LVESDi (LVESD/BSA)＞0.25 mm/m2（对于体型较小的患者）或静息 LVEF≤50% 的患者，推荐在择期中危或高危NCS术之前进行瓣膜手术。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于有症状的重度主动脉瓣反流或无症状的重度主动脉瓣反流，且LVESD＞0.50 毫米或LVESDi (LVESD/BSA)＞0.25 mm/m2（对于体型较小的患者）或静息 LVEF≤50% 的患者，推荐在择期中危或高危NCS术之前进行瓣膜手术。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients with symptomatic severe AR or asymptomatic severe AR and LVESD＞50 mm or LVESDi (LVESD/BSA)＞25 mm/m2 (in patients with small body size) or resting LVEF ≤50%, valve surgery is recommended prior to elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 524
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/524.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with suspected or known HF scheduled for high-risk NCS, it is recommended to evaluate LV function with echocardiography and measurement of NT-proBNP/BNP levels, unless this has recently been performed.(Evidence: Level B，Recommendation: Class Ⅰ)
[laiyuan] => 疑似或已知心衰患者择期行高风险NCS，推荐通过超声心动图评估左室功能及NT-proBNP/BNP 水平，除非最近已进行过此项检查。（证据级别：Level B ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
疑似或已知心衰患者择期行高风险NCS，推荐通过超声心动图评估左室功能及NT-proBNP/BNP 水平，除非最近已进行过此项检查。（证据级别：Level B ；推荐强度：Class Ⅰ）
In patients with suspected or known HF scheduled for high-risk NCS, it is recommended to evaluate LV function with echocardiography and measurement of NT-proBNP/BNP levels, unless this has recently been performed.(Evidence: Level B，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 525
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/525.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => It is recommended that patients with HF undergoing NCS receive optimal medical treatment according to current ESC Guidelines. (Evidence: Level A，Recommendation: Class Ⅰ)
[laiyuan] => 推荐接受NCS的心房颤动患者根据目前ESC指南进行优化治疗。（证据级别：Level A ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
推荐接受NCS的心房颤动患者根据目前ESC指南进行优化治疗。（证据级别：Level A ；推荐强度：Class Ⅰ）
It is recommended that patients with HF undergoing NCS receive optimal medical treatment according to current ESC Guidelines. (Evidence: Level A，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 526
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/526.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with a family history of genetic cardiomyopathy, it is recommended to perform an ECG and TTE before NCS, regardless of age and symptoms. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 在有遗传性心肌病家族史的患者中，推荐在NCS术前行心电图和经胸超声心动图检查，不考虑年龄和症状。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在有遗传性心肌病家族史的患者中，推荐在NCS术前行心电图和经胸超声心动图检查，不考虑年龄和症状。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients with a family history of genetic cardiomyopathy, it is recommended to perform an ECG and TTE before NCS, regardless of age and symptoms. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 527
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/527.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients aged 45–65 years without signs,
symptoms, or history of CVD, ECG and
biomarkers should be considered before high-risk
NCS. (Evidence: Level C，Recommendation: Class Ⅱa)
[laiyuan] => 在没有心血管疾病体征、症状或病史的45-65岁患者中，应在高危NCS术前考虑完善心电图和生物标志物检查。（证据级别：Level C ；推荐强度：Class Ⅱa）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在没有心血管疾病体征、症状或病史的45-65岁患者中，应在高危NCS术前考虑完善心电图和生物标志物检查。（证据级别：Level C ；推荐强度：Class Ⅱa）
In patients aged 45–65 years without signs,
symptoms, or history of CVD, ECG and
biomarkers should be considered before high-risk
NCS. (Evidence: Level C，Recommendation: Class Ⅱa)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 528
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/528.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with a newly detected murmur and
symptoms or signs of CVD, TTE is recommended
before NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 在新检测到到杂音的患者中并存在心血管疾病的症状或体征，建议在NCS之前使用经胸超声心动图评估。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在新检测到到杂音的患者中并存在心血管疾病的症状或体征，建议在NCS之前使用经胸超声心动图评估。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients with a newly detected murmur and
symptoms or signs of CVD, TTE is recommended
before NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 529
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/529.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with a newly detected murmur suggesting clinically significant pathology, TTE is recommended before high-risk NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 在新检测到提示有临床意义病理性杂音的患者，推荐在高风险NCS术前检查超声心动图。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在新检测到提示有临床意义病理性杂音的患者，推荐在高风险NCS术前检查超声心动图。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients with a newly detected murmur suggesting clinically significant pathology, TTE is recommended before high-risk NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
